Innate and adaptive genetic pathways in HCV infection. Issue 4 (24th February 2015)

• Record Type: Journal Article
• Authors: Buchanan, R.; Hydes, T.; Khakoo, S. I.
• Is Part Of: Tissue antigens. Volume 85:Issue 4(2015)
• Page Start: 231
• Page End: 240
• Publication Date: 2015-02-24
• Subjects: hepatitis C -- immunity, adaptive -- immunity, innate -- interferon -- interleukins; Antigens -- Periodicals; Immunological tolerance -- Periodicals; Immunogenetics -- Periodicals; 571.9645
• DOI: 10.1111/tan.12540
• Languages: English
• ISSNs: 0001-2815

Abstract

Abstract: Infection with hepatitis C virus (HCV) leads to a wide spectrum of clinical manifestations. This heterogeneity is underpinned by the host immune response and the genetic factors that govern it. Polymorphisms affecting both the innate and adaptive immunity determine the outcome of exposure. However the innate immune system appears to play a greater role in determining treatment‐associated responses. Overall the effects of IFNL3/4 appear dominant over other polymorphic genes. Understanding how host genetics determines the disease phenotype has not been as intensively studied. This review summarizes our current understanding of innate and adaptive immunogenetic factors in the outcome of HCV infection. It focuses on how they relate to resolution and the progression of HCV‐related liver disease, in the context of current and future treatment regimes.